Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Pharmaceutical companies Stories

2014-04-17 08:27:47

BOSTON, April 17, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) will hold a conference call on April 29, 2014, to discuss financial results of the first quarter ended March 31, 2014. Frank Condella, President and Chief Executive Officer, and Jonathan Lloyd Jones, Vice President and Chief Financial Officer of Columbia Laboratories, will host the call as follows: Date: Tuesday, April 29, 2014 Time: 8:30 am EDT...

2014-04-02 20:22:35

- Centralized Headquarters to help drive Company's Geographic Expansion, Growth in Emerging Markets throughout Southeast Asia - SINGAPORE, April 2, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced the official opening of its new regional office in Singapore that will serve as the headquarters for the Company's Asia Pacific and Africa (APACA) region. In addition, Actavis announced that its subsidiary operating in...

2014-04-01 08:28:47

DUBLIN, April 1, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has successfully completed the divestiture of its generics commercial operations in seven markets in Western Europe to Aurobindo Pharma Limited (BSE: 524804). The agreement to divest the commercial operations was announced in January 2014. http://photos.prnewswire.com/prnvar/20130124/NY47381LOGO Aurobindo acquired Actavis' pharmaceutical commercial infrastructure in France, Italy, Spain,...

2014-01-18 00:20:27

DUBLIN, Jan. 17, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it intends to enter into an agreement for Aurobindo Pharma Limited (BSE: 524804) to acquire Actavis' generics commercial operations in seven markets in Western Europe. The transaction is conditional on certain antitrust approvals and completion of employee consultation processes. Aurobindo would acquire Actavis' pharmaceutical commercial infrastructure in France, Italy, Spain, Portugal, Belgium,...

2014-01-09 08:27:30

HOERSHOLM, Denmark and SAN DIEGO, Jan. 9, 2014 /PRNewswire/ -- Santaris Pharma A/S, a privately held biopharmaceutical company, announced today that they have signed a worldwide strategic alliance with Roche to discover and develop novel RNA targeted medicines using Santaris Pharma's proprietary Locked Nucleic Acid (LNA) Drug Platform. (Logo: http://photos.prnewswire.com/prnh/20100111/SPLOGO) Under the terms of the agreement, Santaris Pharma and Roche will collaborate on the...

2014-01-08 08:28:05

HOERSHOLM, Denmark, SAN DIEGO, and MUNICH, Jan. 8, 2014 /PRNewswire/ -- Santaris Pharma A/S and BetaIsarna Therapeutics GmbH announced today that they have signed an agreement whereby Isarna gains access to Santaris' Locked Nucleic Acid (LNA) technology to further develop its next generation oligonucleotide product candidates. Under the terms of the agreement, Isarna obtains rights to utilize Santaris Pharma's proprietary LNA Drug Platform to discover, develop and commercialize...

2013-10-29 12:26:42

FRANKFURT, Germany, Oct. 29, 2013 /PRNewswire/ -- At CPhI Worldwide in Frankfurt last week, Indian pharma's growth and future were the subject of a number of interviews with key representatives of the Indian government, industry, and the India Brand Equity Foundation (IBEF). The videos, produced by CPhI Pharma Evolution TV (accessible here: www.pharmaevolution.com/archives.asp?videoblogs=yes), examine India's pharma sector from private and public perspectives. What emerges is the image of a...

2013-07-30 08:32:45

BOTHELL, WA and VANCOUVER, BC, July 30, 2013 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's second quarter 2013 financial results will be released on Thursday, August 8, 2013, and that the Company will host a conference call and live webcast at 4:30 p.m. ET that afternoon. Management will provide an overview of clinical development activities and discuss the company's financial results. To access the webcast, log on to the...

2013-07-16 08:26:26

NEW YORK, July 16, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Wall Street Reports announced new research reports highlighting Mylan Inc. (NASDAQ: MYL), Actavis, Inc. (NYSE: ACT), Warner Chilcott Plc (NASDAQ: WCRX), Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), and Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR). Today's readers may access these reports free of charge - including full price targets, industry...

2013-06-28 08:22:48

NEW YORK, June 28, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Wall Street Reports announced new research reports highlighting Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Actavis Inc. (NYSE: ACT), CombiMatrix Corporation (NASDAQ: CBMX), Globus Medical Inc. (NYSE: GMED), and Teleflex Incorporated (NYSE: TFX). Today's readers may access these reports free of charge - including full price targets, industry...